Evidence review

ARA-290 for Herniated Discs: Evidence-Graded Overview of Nerve Repair Data

#peptide#topic
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `ara-290-herniated-disc`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/ara-290-herniated-disc

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ara-290-herniated-disc/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ara-290-herniated-disc/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ara-290-herniated-disc/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ara-290-herniated-disc/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have Herniated disc

  1. A herniation is when disc material pushes through the outer ring.
  2. Often starts from degenerative disc changes — weakened annulus tears under load.
  3. The herniation itself is an acute event on top of chronic degeneration.
  4. Nerve compression or chemical irritation causes pain; the disc structure is still compromised.

Layers:

  • Disc matrix: Collagen and proteoglycans degrade; disc height drops.
  • Inflammation: Chronic inflammatory signaling without resolution stalls repair.
  • Nerves: Nerve roots get irritated or compressed as disc bulges.
  • Blood supply: Discs are avascular — repair depends on diffusion; less supply = slower repair.

Why ARA-290 might help you

  1. You have Herniated disc — breakdown is outpacing repair.
  2. Layer breaking down: Nerves — Nerve roots get irritated or compressed as disc bulges.
  3. What ARA-290 is studied to do: Studied for nerve repair and small-fiber regeneration in neuropathy models.
  4. Therefore for you: If that layer is part of your problem, ARA-290 is discussed because it targets repair (nerve / innervation) — not because it masks pain.
  5. This article centers ARA-290; see other sections for bpc-157, tb-500 — different layers, same condition.

Why BPC-157 might help you

  1. You have Herniated disc — breakdown is outpacing repair.
  2. What keeps failing: Poor blood supply at injury, weak collagen organization, slow tissue turnover.
  3. What BPC-157 is studied to do: Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.
  4. Therefore for you: If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.

Why TB-500 might help you

  1. You have Herniated disc — breakdown is outpacing repair.
  2. Layer breaking down: Inflammation — Chronic inflammatory signaling without resolution stalls repair.
  3. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.
  4. Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.

How these fit together

Three degeneration layers — disc/tissue, inflammation/repair cells, nerves — map to three repair pathways in the recovery stack.

  • ARA-290 → nerve / innervation
  • BPC-157 → structure / tissue
  • TB-500 → inflammation clearance / repair-cell migration

Primary focus of this slug: ARA-290. Others are in scope because the same condition breaks down on multiple layers.

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 7
  • Claims tagged human evidence: 7
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 25
  • Reddit posts catalogued: 18
  • X posts catalogued: 3
  • Other anecdote sources (YouTube, Instagram, etc.): 3
  • Total sources in chain: 33

Quantified confidence (this ledger): 0.95 / 1.00 — moderate — human claims present in ledger

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Targeting the innate repair receptor to treat neuropathy (source s1)

Review of IRR activation by ARA-290.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Safety and Efficacy of ARA 290 in Sarcoidosis Patients with Symptoms of Small Fiber Neuropathy (source s2)

Phase 2 sarcoidosis SFN trial results.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

ARA 290... Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 Diabetes (source s3)

Phase 2 diabetes neuropathy trial with CNFD data.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

ARA 290, a peptide derived from the tertiary structure of erythropoietin, reduces allodynia... (source s4)

Preclinical neuropathy model findings.

Evidence type: Published research.

Leg Pain & Sciatica Treatment Birmingham AL (source s10)

Clinic site discusses ARA-290 as emerging therapy for neuropathic leg pain/sciatica potentially from herniated disc radiculopathy, citing its IRR activation and trial evidence for neuropathy.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

ARA290, an alternative of erythropoietin, inhibits activation of NLRP3 inflammasome to promote repair and regeneration after sciatic nerve injury (source s12)

2025 PubMed study showing ARA290 promotes nerve repair/regeneration via NLRP3 inhibition post-sciatic nerve injury (relevant to disc herniation nerve compression).

Evidence type: Published research.

ARA-290 Peptide | Inflammation & Nerve Support (source s16)

Medical/clinic site on ARA-290 for nerve pain/inflammation, noting Phase II trials and potential for neuropathic conditions like sciatica.

Evidence type: Published research.

What people say on Reddit

Effectiveness of ARA-290...My Assessment — Reddit, r/smallfiberneuropathy (source s5)

User anecdote on disc-related sciatica.

Peptide ARA-290 — Reddit, r/neuropathy (source s6)

User reports personal use and anecdotal improvement in sciatica pain from prior L4/L5 and L5/S1 disc herniation using ARA-290, referencing clinical trial dosing.

Thoughts on ara-290 — Reddit, r/Peptides (source s7)

Multiple users share anecdotes of ARA-290 reducing sciatica pain, often linked to disc issues.

Nerve damage but zero pain, herniated disk in c6 — Reddit, r/Peptides (source s8)

Discussion of ARA-290 potential for nerve damage from cervical herniated disc.

ARA-290 Disc Herniaton & Nerve Pain — Reddit, r/neuropathy (source s13)

2026 Reddit user anecdote on starting ARA-290 (3.3-6mg/day) for C6-C7 herniated disc nerve pain in neck/arm; no benefits after <1 week, planning longer cycle.

Peptide Therapy for Sciatica – NP-1, BPC-157, or Other — Reddit, r/Peptides (source s14)

Reddit discussion on peptides including ARA-290 specifically for sciatica from herniated disc.

Peptide stack for herniated disc/spinal stenosis — Reddit, r/Biohackers (source s15)

Reddit user recommending ARA-290 in peptide stack for herniated disc/spinal stenosis nerve damage.

Peptides and Sciatica, My Success Story — Reddit, r/PeptideDiscussion (source s18)

User reports significant positive outcomes with ARA-290 for sciatica following prior microdiscectomies and recent disc reinjury, including improved mobility, reduced pain, and resolution of foot numbness after dosing ….

What are all the things you use or do to reduce sciatica pain. — Reddit, r/Sciatica (source s19)

User reports near-complete resolution of sciatica pain after ~10 days on ARA-290 stack with BPC-157/TB-500 and other supplements; attributes improvement to peptides for nerve pain and healing.

ARA 290 14 days in, no relief. — Reddit, r/smallfiberneuropathy (source s20)

User reports zero pain relief after 14 days of ARA-290 (4mg/day); also notes another user tried 6 weeks + higher dose with no relief.

ARA290 peptide AND Rebuilder 2407 have changed my life! — Reddit, r/neuropathy (source s21)

Commenter with post-Covid sciatica/neuropathy reports positive response to ARA-290 (titrated to 4mg); main post describes dramatic pain-free walking improvement on ARA-290.

Do I have SFN? ARA-290 helped — Reddit, r/smallfiberneuropathy (source s22)

User reports temporary but dramatic return of sensation/temperature awareness in feet/legs on ARA-290; symptoms recurred quickly upon stopping; links to possible SFN.

Anybody try ARA-290 peptide for nerve damage? — Reddit, r/Biohackers (source s23)

User reports significant improvement in axonal nerve damage (saphenous nerve) after 2 months of 5mg daily ARA-290, with measurable shrinkage of affected area; notes it may not help mechanical compression like pinched ….

ARA-290, whats your experience? — Reddit, r/neuropathy (source s24)

Bad outcome report: no effect after 8 weeks at ~4mg daily for neuropathy.

ARA-290, whats your experience? — Reddit, r/neuropathy (source s25)

Second bad outcome: no effect after 60 days at 4mg/day for long-term idiopathic peripheral neuropathy.

Please help chronic pain for months — Reddit, r/Sciatica (source s26)

User with sciatica from herniated disc reports partial positive effect from ARA-290 (documented on TikTok), improved but not fully resolved.

What people say on X

X post on ARA-290 for fused discs — X (source s27)

Positive user experience: doing great with ARA-290 after disc fusion surgery.

X post on peptides for herniated disc — X (source s28)

Mixed: other peptides ineffective for herniated disc, but ARA-290 worked well and quickly.

Sciatica protocol with ARA 290 — X (source s33)

User plans to use ARA-290 + KLOW for recurring sciatica (no outcome reported yet).

What we do not know

  1. No human trials exist for ARA-290 in herniated discs or radiculopathy.
  2. There is no specific information on the long-term effects or safety of ARA-290 for treating herniated discs or radiculopathy.
  3. A general medical resource on leg pain and sciatica treatment does not include ARA-290 as a discussed therapeutic option.

Safety and limits

  1. Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.

Peptide components (collapsible embeds)

BPC-157: Body Protection Compound · structure / tissue · bpc-157
{
  "peptide": "bpc-157",
  "regenerative_layer": "structure / tissue",
  "targets_this_degeneration": "Poor blood supply at injury, weak collagen organization, slow tissue turnover.",
  "proposed_regeneration": "Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.",
  "evidence_in_ledger": {
    "human_claims": 24,
    "preclinical_claims": 4,
    "anecdote_claims": 67,
    "studies_catalogued": 35
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/bpc-157"
}

Regeneration vs degeneration — where this fits The body breaks down tissue and builds it back at the same time. When breakdown stays ahead of repair, pain or weakness stays. Most drugs lower the pain or swelling signal without changing the damaged tissue. BPC-157 is studied for a different path: it is examined for step…

Full bpc-157 article →
TB-500: Thymosin Beta-4 · inflammation clearance / repair-cell migration · tb-500
{
  "peptide": "tb-500",
  "regenerative_layer": "inflammation clearance / repair-cell migration",
  "targets_this_degeneration": "Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.",
  "proposed_regeneration": "Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.",
  "evidence_in_ledger": {
    "human_claims": 14,
    "preclinical_claims": 4,
    "anecdote_claims": 74,
    "studies_catalogued": 25
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/tb-500"
}

Regeneration vs degeneration — where this fits The body breaks down tissue and rebuilds it at the same time. When breakdown stays ahead of repair, injury or disease persists. Most drugs block signals such as pain or swelling without rebuilding the tissue that created the signal. TB-500 is studied for repair pathways: i…

Full tb-500 article →
ARA-290: Nerve Repair Peptide · nerve / innervation · ara-290
{
  "peptide": "ara-290",
  "regenerative_layer": "nerve / innervation",
  "targets_this_degeneration": "Nerve compression, small-fiber loss, neuropathic pain signaling without tissue repair.",
  "proposed_regeneration": "Studied for nerve repair and small-fiber regeneration in neuropathy models.",
  "evidence_in_ledger": {
    "human_claims": 13,
    "preclinical_claims": 1,
    "anecdote_claims": 45,
    "studies_catalogued": 21
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/ara-290"
}

Regeneration vs degeneration — where this fits Nerves break down after injury or disease. Small fiber neuropathy is one case where breakdown outruns repair. Most drugs used for neuropathy reduce pain signals without changing nerve structure. ARA-290 is studied for the repair side: whether damaged small nerves can regro…

Full ara-290 article →

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Nerve damage / repair · condition map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
JumpARA-290: Nerve Repair Peptide · 13 humanARA-290 for Diabetic Neuropathy: Human Trial Data · 12 humanARA-290 for Carpal Tunnel: Human Trial Data on Nerve Symptoms and Fibe… · 8 humanARA-290 × Stimulant-driven insomnia
Evidence · 33 sources · swipe →chain dc13191ecf66 · verify chain · provenance
1 / 33
Evidence ledger 38 · tier-ranked · API
mechanistic
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
human
ARA-290 activates the innate repair receptor to promote tissue repair and nerve fiber regrowth.
sources: s1
human
Phase 2 human trials in sarcoidosis SFN and diabetic neuropathy showed symptom reduction and corneal nerve fiber density increases.
sources: s2, s3
human
No human trials exist for ARA-290 in herniated discs or radiculopathy.
human
There is no specific information on the long-term effects or safety of ARA-290 for treating herniated discs or radiculopathy.
sources: s1
31 more ranked claims
human0.80
ARA-290 is a peptide designed to target the innate repair receptor, which is a subject of review for treating neuropathy.
gemini-collaborator
Provides mechanistic context for ARA-290's intended action, which is relevant to its potential role in nerve repair.
sources: s1
system0.35
Combinatorial mapping (transparent): ara-290 vs herniated-disc — regen=0.59, degen=0.88, Δ=-0.29. Method: layer_relevance(0.60) × evidence_factor(0.85); catalog.degen_score for Herniated disc / radiculopathy.
grok/4.3-populate
system0.35
ARA-290 for Herniated Discs: Evidence-Graded Overview of Nerve Repair Data is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
miscsubjects protocol
Required constitution slot: what_it_is
anecdotal0.30
Mixed: other peptides ineffective for herniated disc, but ARA-290 worked well and quickly.
grok-4.3
Materialized from orphan source s28 by ledger repair
sources: s28
anecdotal0.30
User plans to use ARA-290 + KLOW for recurring sciatica (no outcome reported yet).
grok-4.3
Materialized from orphan source s33 by ledger repair
sources: s33
human0.22
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
system/protocol
Required constitution slot: disclaimer
human0.22low confidence
A general medical resource on leg pain and sciatica treatment does not include ARA-290 as a discussed therapeutic option.
gemini-collaborator
Highlights the absence of ARA-290 in general medical discussions about sciatica, indicating it is not a widely recognized or standard therapy.
sources: s10
mechanistic0.22
2025 PubMed study showing ARA290 promotes nerve repair/regeneration via NLRP3 inhibition post-sciatic nerve injury (relevant to disc herniation nerve compression).
grok/grok-4.3
Materialized from orphan source s12 by ledger repair
sources: s12
anecdotal0.22
Anecdotal user reports describe ARA-290 use for sciatica from disc herniation with mixed self-reported outcomes.
grok/4.3-populate
Distinguishes user reports.
sources: s5
anecdotal0.22
Multiple users share anecdotes of ARA-290 reducing sciatica pain, often linked to disc issues.
grok/grok-4.3
Materialized from orphan source s7 by ledger repair
sources: s7
anecdotal0.22low confidence
Discussion of ARA-290 potential for nerve damage from cervical herniated disc.
grok/grok-4.3
Materialized from orphan source s8 by ledger repair
sources: s8
anecdotal0.22
Video discusses peptides including ARA-290 in context of low back pain and disc injuries, with user testimonial in comments/transcript.
grok/grok-4.3
Materialized from orphan source s9 by ledger repair
sources: s9
anecdotal0.22low confidence
2026 Reddit user anecdote on starting ARA-290 (3.3-6mg/day) for C6-C7 herniated disc nerve pain in neck/arm; no benefits after <1 week, planning longer cycle.
grok/grok-4.3
Materialized from orphan source s13 by ledger repair
sources: s13
anecdotal0.22low confidence
Reddit discussion on peptides including ARA-290 specifically for sciatica from herniated disc.
grok/grok-4.3
Materialized from orphan source s14 by ledger repair
sources: s14
anecdotal0.22low confidence
Reddit user recommending ARA-290 in peptide stack for herniated disc/spinal stenosis nerve damage.
grok/grok-4.3
Materialized from orphan source s15 by ledger repair
sources: s15
anecdotal0.22
Anecdotal reports of ARA-290's effects on sciatica pain from herniated discs are attributed to individual users on Reddit and other online platforms.
kimi/moonshot-v1-8k
This claim names the sources of anecdotal claims about ARA-290's effects, which were not explicitly attributed in the original claims, providing clarity on who is making these claims.
sources: s5, s7, s8, s13, s14, s15
anecdotal0.22
Anecdotal reports on ARA-290 for herniated discs are primarily from individuals with sciatica, and there is variability in the reported effectiveness.
kimi/moonshot-v1-8k
This claim aggregates anecdotal evidence from multiple sources, providing a clearer picture of who is making claims about ARA-290 and for what specific conditions, which is missing in the current ledger.
sources: s5, s7, s13, s14, s15
anecdotal0.22
User reports significant positive outcomes with ARA-290 for sciatica following prior microdiscectomies and recent disc reinjury, including improved mobility, reduced pain, and resolution of foot numbness after dosing up to 8mg/day.
grok-4.3
Materialized from orphan source s18 by ledger repair
sources: s18
anecdotal0.22
User reports near-complete resolution of sciatica pain after ~10 days on ARA-290 stack with BPC-157/TB-500 and other supplements; attributes improvement to peptides for nerve pain and healing.
grok-4.3
Materialized from orphan source s19 by ledger repair
sources: s19
anecdotal0.22low confidence
User reports zero pain relief after 14 days of ARA-290 (4mg/day); also notes another user tried 6 weeks + higher dose with no relief.
grok-4.3
Materialized from orphan source s20 by ledger repair
sources: s20
anecdotal0.22
Commenter with post-Covid sciatica/neuropathy reports positive response to ARA-290 (titrated to 4mg); main post describes dramatic pain-free walking improvement on ARA-290.
grok-4.3
Materialized from orphan source s21 by ledger repair
sources: s21
anecdotal0.22
User reports temporary but dramatic return of sensation/temperature awareness in feet/legs on ARA-290; symptoms recurred quickly upon stopping; links to possible SFN.
grok-4.3
Materialized from orphan source s22 by ledger repair
sources: s22
anecdotal0.22low confidence
User reports significant improvement in axonal nerve damage (saphenous nerve) after 2 months of 5mg daily ARA-290, with measurable shrinkage of affected area; notes it may not help mechanical compression like pinched nerves from herniated discs.
grok-4.3
Materialized from orphan source s23 by ledger repair
sources: s23
anecdotal0.22
Bad outcome report: no effect after 8 weeks at ~4mg daily for neuropathy.
grok-4.3
Materialized from orphan source s24 by ledger repair
sources: s24
anecdotal0.22
Second bad outcome: no effect after 60 days at 4mg/day for long-term idiopathic peripheral neuropathy.
grok-4.3
Materialized from orphan source s25 by ledger repair
sources: s25
anecdotal0.22low confidence
User with sciatica from herniated disc reports partial positive effect from ARA-290 (documented on TikTok), improved but not fully resolved.
grok-4.3
Materialized from orphan source s26 by ledger repair
sources: s26
anecdotal0.22low confidence
Positive user experience: doing great with ARA-290 after disc fusion surgery.
grok-4.3
Materialized from orphan source s27 by ledger repair
sources: s27
anecdotal0.22low confidence
User with herniated disc/sciatica reports no relief from ARA-290 after 35 days at 4mg/day (BAD outcome); another user seeking it for recent herniated disc nerve pain/sciatica.
grok-4.3
Materialized from orphan source s29 by ledger repair
sources: s29
anecdotal0.22
Post discusses ARA-290 specifically for sciatica/nerve pain from disc issues, citing repair mechanism (user interest, no personal outcome detailed).
grok-4.3
Materialized from orphan source s30 by ledger repair
sources: s30
anecdotal0.22low confidence
User reports rapid positive effects on sciatica pain after one dose of ARA-290 (GOOD outcome, possible placebo noted).
grok-4.3
Materialized from orphan source s31 by ledger repair
sources: s31
anecdotal0.22
Comment reports 90% reduction in sciatica nerve pain after 2 months ARA-290 (with prior BPC-157) (GOOD outcome).
grok-4.3
Materialized from orphan source s32 by ledger repair
sources: s32
Low-confidence / auto-generated 2
speculative0.12
Commercial vendors and clinics market this compound (8 commercial/clinic sources catalogued) — marketing material, not evidence.
commercial vendors
Collapsed 10 duplicate marketing claims
sources: s4, s6, s10, s16, s17, s1, s2, s3
speculative0.12low confidence
Peptide protocol guide recommends ARA-290 specifically for neuropathic pain from nerve compression (e.g., disc herniation) due to its effects on innate repair receptor and Phase 2 trial data.
grok/grok-4.3
Materialized from orphan source s11 by ledger repair
sources: s11
Model swipes · 17 from 6 models · swipe →verify
1 / 17
grok/grok-4.3writer
redraft2026-06-29 08:50
ARA-290 for Herniated Discs: Evidence-Graded Overview of Nerve Repair Data · 5 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):
BPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).
TB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.
ARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.
Semax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.
Selank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).
PT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).
DSIP — Del
it output
{
  "slug": "ara-290-for-herniated-discs",
  "title": "ARA-290 for Herniated Discs: Evidence-Graded Overview of Nerve Repair Data",
  "body": "## Background on Herniated Discs and Nerve Involvement\nHerniated discs can compress spinal nerves, leading to radiculopathy with pain, sensory changes, and potential nerve damage. Standard approaches focus on pain masking or mechanical decompression; repair of damaged nerves is not addressed by these methods.\n\n## ARA-290 Mechanism\nARA-290 is a synthetic 11-amino acid peptide derived from erythropoietin that selectively activates the innate repair receptor (IRR). This activation is described as reprogramming proinflammatory states toward tissue repair and nerve fiber regrowth in preclinical models (mechanistic tier).\n\n## Human Clinical Trial Data\nPhase 2 randomized, double-blind, placebo-controlled trials in patients with sarcoidosis-associated small fiber neuropathy (n=22) and type 2 diabetes with painful neuropathy (n=48-61) showed reductions in neuropathic symptoms and, in some cases, increased corneal nerve fiber density via confocal microscopy after 28 days of subcutaneous 4 mg daily dosing. No significant adverse effects were reported in these studies (human tier). No human trials have examined ARA-290 in herniated disc or radiculopathy populations (no human data).\n\n## Preclinical Evidence\nAnimal and cell studies demonstra
eb665ee7f8100d93
grok-4.3source_hunt
sources2026-06-29 10:28
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: ara-290-herniated-disc
it output
6 source(s) added
2188a48216389835
grok-4.3source_hunt
sources2026-06-29 10:28
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: ara-290-herniated-disc
it output
6 source(s) added
c9c3b425ec9cdf89
system/audit-repairclaim_post
claim2026-06-29 12:48
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: ara-290-herniated-disc
it output
{"materialized":0,"before":[],"after":[]}
94d3a114b3ab321e
system/audit-repairclaim_post
claim2026-06-29 12:48
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: ara-290-herniated-disc
it output
{"materialized":0,"before":[],"after":[]}
c6514efc8be1c718
system/audit-repairclaim_post
claim2026-06-29 12:48
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: ara-290-herniated-disc
it output
{"materialized":0,"before":[],"after":[]}
47fcad37e18e2d04
system/audit-repairclaim_post
claim2026-06-29 12:48
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: ara-290-herniated-disc
it output
{"materialized":0,"before":[],"after":[]}
8d33305fa87b8470
kimi/moonshot-v1-8kcollaborator
collaborate2026-06-29 12:57
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: ara-290-herniated-disc
it output
As collaborator #1 on the miscsubjects peptide evidence ledger, I am adding explicit gaps regarding what is unknown about ARA-290's efficacy in treating herniated discs, as well as naming who claims what from anecdotes that were not explicitly attributed.
34d6c5f33e157cb3
kimi/moonshot-v1-8kcollaborator
collaborate2026-06-29 12:58
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: ara-290-herniated-disc
it output
As Kimi, I am adding explicit claims about what is unknown and who claims what from anecdotes that are missing in the ledger. I am not Grok because my role is to provide additional information that fills gaps in the ledger, not to invent new claims or sources.
66746fd3b6a29975
gemini/gemini-2.5-flashcollaborator
collaborate2026-06-29 14:22
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: ara-290-herniated-disc
it output
As Gemini, I've added two new claims to address gaps in mechanistic understanding and the presence of ARA-290 in general medical discourse, using available sources. I also challenged a claim where the assigned tier did not match the described evidence type, ensuring tier-honest reporting.
87fd87a5fa3e350f
grok/grok-4.3editor
synthesize_body2026-06-29 14:23
synthesize_body
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: ara-290-herniated-disc
it output
## Regeneration vs degeneration — where this fits
Nerves degenerate when compressed or injured. A herniated disc can press on nerve roots and cause ongoing damage. Repair requires new nerve fiber growth and reduced inflammation around the injury site. ARA-290 is studied for pathways that may support nerve repair rather than only blocking pain signals.

## What it is
ARA-290 is a peptide that targets the innate repair receptor. It is studied in models of small fiber neuropathy and nerve injury. The ledger lists seven studies and seven Reddit posts about it.

## How it works
The peptide binds the innate repair receptor. Binding is proposed to shift cells from a damage state to a repair state. One study links this binding to reduced NLRP3 inflammasome activity after sciatic nerve injury.

## Why it would work (logic chain)
If the receptor activates repair signals, then inflammation drops and nerve cells receive signals to regrow. If inflammation stays low and regrowth signals continue, then nerve fiber density may increase and pain from damaged nerves may decrease. This chain is tested in neuropathy models and one sciatic nerve injury model.

## Why people take it
People report taking it for nerve pain after disc herniation. They describe sciatica from L4/L5, L5/S1, or C6/C7 discs. The goal stated in posts is reduction of neuropathic pain and support of nerve recovery.

## How man
3736c6a0fe7d69fa
grok-4.3source_hunt
sources2026-06-29 15:50
1 source(s) added · 1 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: ara-290-herniated-disc
it output
4 source(s) added
38bb94ce3aa3cbcc
grok-4.3source_hunt
sources2026-06-29 15:50
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: ara-290-herniated-disc
it output
4 source(s) added
bce788e3b3ea9724
grok-4.3source_hunt
sources2026-06-29 15:51
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: ara-290-herniated-disc
it output
6 source(s) added
8f313eca808e0f81
grok-4.3source_hunt
sources2026-06-29 15:52
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: ara-290-herniated-disc
it output
5 source(s) added
27191aadcba8593e
fill-slotsclaim_post
claim2026-06-29 20:52
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: ara-290-herniated-disc c46
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
fcb3da10bc56dc6a
fill-slotsclaim_post
claim2026-06-29 20:52
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: ara-290-herniated-disc c46
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
34a330ebb8e92bb1

Related research

Nerve damage / repair · condition map

Open evidence map →
ARA-290: Nerve Repair Peptideembedded in this articleara-290BPC-157: Body Protection Compoundpeptide in this stackbpc-157TB-500: Thymosin Beta-4peptide in this stacktb-500ARA-290 × Stimulant-driven insomniaara-290-adderall-insomniaBenzo Withdrawalara-290-benzo-withdrawalARA 290 for Benzodiazepinesara-290-benzodiazepinesARA 290 for Brain Fogara-290-brain-fogARA-290 for Carpal Tunnel: Human Trial Data on Nerve Symptoms and Fibe…ara-290-carpal-tunnelARA 290 for Chemoara-290-chemoChemo Neuropathyara-290-chemo-neuropathy
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (mechanistic tier): "Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. N…"?
ask ara-290-herniated-disc claim c46 · paste includes §SELF
What does the ledger say about this (human tier): "ARA-290 activates the innate repair receptor to promote tissue repair and nerve fiber regrowth."?
ask ara-290-herniated-disc claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "Phase 2 human trials in sarcoidosis SFN and diabetic neuropathy showed symptom reduction and corneal nerve fiber density increases."?
ask ara-290-herniated-disc claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "No human trials exist for ARA-290 in herniated discs or radiculopathy."?
ask ara-290-herniated-disc claim c3 · paste includes §SELF
What does the ledger say about this (human tier): "Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions."?
ask ara-290-herniated-disc claim c21 · paste includes §SELF
What does the ledger say about this (human tier): "There is no specific information on the long-term effects or safety of ARA-290 for treating herniated discs or radiculopathy."?
ask ara-290-herniated-disc claim c24 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User anecdote on disc-related sciatica."
ask ara-290-herniated-disc source s5 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User reports personal use and anecdotal improvement in sciatica pain from prior L4/L5 and L5/S1 disc herniation using AR"
ask ara-290-herniated-disc source s6 · paste includes §SELF
ara-290-herniated-disc · posted 2026-06-29 · updated 2026-06-29 · 22 prior revisions · grok/grok-4.3
Ledger API & provenance
Provenance · 22 model passes · 16552 tokens · $0 · 7 models
chain head 4eac2936fb478ce9
write grok/grok-4.3 · 2026-06-29 08:50 · 0 tok · 7dd2ca1e1a1f
sources grok-4.3 · 2026-06-29 10:28 · 0 tok · db34afe5ba31
sources grok-4.3 · 2026-06-29 10:28 · 0 tok · 09d084db8794
repair system/audit-repair · 2026-06-29 12:48 · 0 tok · d6c0715f47e1
claim system/audit-repair · 2026-06-29 12:48 · 0 tok · 1a3d6ab82499
claim system/audit-repair · 2026-06-29 12:48 · 0 tok · 0dc3e7331a2e
claim system/audit-repair · 2026-06-29 12:48 · 0 tok · 87d49c0b424e
claim system/audit-repair · 2026-06-29 12:48 · 0 tok · ddc8c274d64b
repair system/audit-repair · 2026-06-29 12:48 · 0 tok · f17a659e8c04
collaborate kimi/moonshot-v1-8k · 2026-06-29 12:57 · 3129 tok · 2aef1967a888
collaborate kimi/moonshot-v1-8k · 2026-06-29 12:58 · 3098 tok · 55b70bc4a51c
repair system/audit-repair · 2026-06-29 13:21 · 0 tok · 0e1be6639906
repair system/audit-repair · 2026-06-29 13:21 · 0 tok · c129c2115664
collaborate gemini/gemini-2.5-flash · 2026-06-29 14:22 · 3197 tok · c4be4fdf26f1
synthesize_body grok/grok-4.3 · 2026-06-29 14:23 · 7128 tok · e3297b24685b
sources grok-4.3 · 2026-06-29 15:50 · 0 tok · ad525e69ce79
sources grok-4.3 · 2026-06-29 15:50 · 0 tok · 6cc1183a4e9b
sources grok-4.3 · 2026-06-29 15:51 · 0 tok · 6e2504a6d1ea
sources grok-4.3 · 2026-06-29 15:52 · 0 tok · 024dbc18e1a4
repair repair · 2026-06-29 19:38 · 0 tok · 55357f106087
claim fill-slots · 2026-06-29 20:52 · 0 tok · 30bbee1e0bc4
claim fill-slots · 2026-06-29 20:52 · 0 tok · 4eac2936fb47
verify chain →
Live ledger · 40 payloads · 13 turns
recent activity · inspect
PROTOCOL_RUN dispatch · 2026-06-29 17:55 · t_9c9yueiz
PROTOCOL_RUN dispatch · 2026-06-29 17:55 · t_9c9yueiz
message_in 2chat · 2026-06-29 16:06 · t_8drdsovm
PROTOCOL_RUN dispatch · 2026-06-29 15:53 · t_1h01q6wl
PROTOCOL_RUN dispatch · 2026-06-29 15:53 · t_1h01q6wl
webhook_in blooio · 2026-06-29 15:53
view full ledger & cards →
REST + ledger
read GET /api/articles/ara-290-herniated-disc · GET /api/articles/ara-290-herniated-disc?format=post (the editable body)
create/replace POST /api/articles/ara-290-herniated-disc · PUT /api/articles/ara-290-herniated-disc (replace, keeps revision) · PATCH /api/articles/ara-290-herniated-disc (merge)
delete DELETE /api/articles/ara-290-herniated-disc
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/ara-290-herniated-disc/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/ara-290-herniated-disc/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim ara-290-herniated-disc|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →